转录因子
未折叠蛋白反应
原发性硬化性胆管炎
氧化应激
肝细胞
癌症研究
转录组
胆汁淤积
医学
骨小管
诱导剂
疾病
下调和上调
基因
生物
细胞
发病机制
内生
信号转导
基因表达调控
胆盐出口泵
内科学
细胞生物学
生物信息学
抄写(语言学)
XBP1型
免疫学
肝细胞核因子
转基因
基因表达
增生
肝病
内分泌学
作者
Lianyuan Tao,Peng He,Jiachen Ge,Qifei Guan,Erpei Wang,Ipsita Mohanty,Cristina Bez,Won-Suk Song,Ling Lan,Jingjing Qi,Yueqi Zhang,Peng Zhang,Yuxiao Liu,Avinash Mukkala,Yechen Feng,Mandy Zhu,Qiong Zhou,Tingting Ai,Kosuke Watari,Laura Antonucci
标识
DOI:10.1073/pnas.2616211123
摘要
primary sclerosing cholangitis (PSC) is a severe liver disease that can progress to cholangiocarcinoma. Therapeutic development has been hindered by the rarity of PSC and by its poorly understood origin, which reflects incompletely defined genetic and environmental risk factors. Here we describe a mouse model that combines two suspected environmental risk factors, hepatocyte-intrinsic ER stress and oxidative stress, which leads to activation of transcription factor NRF2 in both hepatocytes and cholangiocytes. Genetically affected mice, as well as mice treated with an ER stress inducer and an NRF2 activator, progressed to PSC with human-like features. Specifically, hepatocyte-intrinsic ER stress in cooperation with activated NRF2 leads to indirect activation of JNK-JUN signaling, which abrogates HNF1α-stimulated Fxr gene transcription and reduces expression of the bile salt export pump BSEP. These signaling abnormalities, whose clinical relevance is supported by single cell transcriptomics of human PSC tissue, cause cholestasis, hepatocyte and bile canaliculi injury, biliary hyperplasia, and periductular fibrosis, which define PSC. Congruently, alleviation of cholestasis and/or inhibition of biliary hyperplasia resolve PSC in mice.
科研通智能强力驱动
Strongly Powered by AbleSci AI